Use of PET-CT in the Management of Crohn's Disease

Stopped early

Conditions studied: Crohn's Disease

In brief

Crohn's disease (CD) is an autoimmune disorder which affects over 700,000 people in the U.S. The disease can vary in severity and multiple drug classes are available to the disease depending on disease severity and complications. Our purpose will be to study how PET-CT scans can be used to better manage Crohn's Disease.

Key facts

Study ID

NCT01182467

Run by

Columbia University

People needed

5

Starts

2011-02-01

Expected to finish

2013-09-01

Last updated by the study team

2015-04-10

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Crohn's disease
• CDAI1>220
• Identification of small bowel disease based on an imaging study (CT scan, Abdominal ultrasound, MRI), colonoscopy, or histopathology 4. Need for initiation of biologic therapy to control disease process.

You may not qualify if…

• Abdominal surgery within 8 wks of study entry
• Change in dose of steroids or immunomodulators within 2wks of study entry
• Pregnancy
• Active bacterial infection or undrained abscess
• Any contraindications to initiation of AntiTNF therapy (i.e. latent tuberculosis).

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.